<?xml version="1.0" encoding="UTF-8"?>
<p>Remdesivir has broad-spectrum antiviral activity because it is an adenosine analog that can determine pre-mature termination of viral RNA (
 <xref rid="B108" ref-type="bibr">108</xref>, 
 <xref rid="B112" ref-type="bibr">112</xref>). It is currently being tested for treatment of Ebola virus infection and, in the future, might be useful to treat several other RNA virus infections (
 <xref rid="B112" ref-type="bibr">112</xref>, 
 <xref rid="B115" ref-type="bibr">115</xref>). Wang et al. (
 <xref rid="B112" ref-type="bibr">112</xref>) showed that viral infections in a human cell line, which is sensitive to SARS-CoV-2, could be inhibited by remdesivir.
</p>
